Entering text into the input field will update the search result below

Adagio names David Hering as permanent CEO and Director

Jul. 05, 2022 7:34 AM ETInvivyd, Inc. (IVVD) StockBy: Niloofer Shaikh, SA News Editor1 Comment
  • Adagio Therapeutics (NASDAQ:ADGI) has named interim chief executive officer and chief operating officer David Hering, as company’s permanent CEO and a director on the board.
  • “As COVID-19 continues to infect millions worldwide, we are committed to the ongoing advancement of Adagio’s founding

Recommended For You

Comments (1)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Destroying my portfolio!!!

About IVVD Stock

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Invivyd, Inc.
Verastem, Inc.
Aldeyra Therapeutics, Inc.
Prelude Therapeutics Incorporated
XOMA Corporation
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.